195 related articles for article (PubMed ID: 7084847)
1. [Benefit-risk considerations in metamizole treatment. Rational recommendations for indications and contra-indications according to current knowledge].
Ell C; Domschke S; Domschke W
Fortschr Med; 1982 Apr; 100(14):615-8. PubMed ID: 7084847
[No Abstract] [Full Text] [Related]
2. [Case report on an anaphylactic shock following intravenous administration of analgin (sodium noraminophenazonemethanesulfonate) with fatal outcome].
Machalett H
Z Arztl Fortbild (Jena); 1978 Mar; 72(6):280-2. PubMed ID: 149436
[No Abstract] [Full Text] [Related]
3. [The use of metamizole as a risk factor in the occurrence of agranulocytosis].
Vlakhov V; Bakracheva N; Popova L
Vutr Boles; 1988; 27(2):80-5. PubMed ID: 3046147
[TBL] [Abstract][Full Text] [Related]
4. [Agranulocytosis and metamizole].
Hoerder U; König HJ; Hartwich G
Dtsch Med Wochenschr; 1982 Dec; 107(50):1923-6. PubMed ID: 7140576
[TBL] [Abstract][Full Text] [Related]
5. Metamizole: a 100-year-old grief.
Levy M; Shapiro S
Ned Tijdschr Geneeskd; 1987 Sep; 131(38):1680-3. PubMed ID: 3670467
[No Abstract] [Full Text] [Related]
6. [Agranulocytosis and metamizole].
Ugeskr Laeger; 1982 Mar; 144(11):813. PubMed ID: 7101514
[No Abstract] [Full Text] [Related]
7. [Metamizole: an unbearable risk?].
Forth W
MMW Munch Med Wochenschr; 1981 Jul; 123(28):1135-7. PubMed ID: 6790946
[No Abstract] [Full Text] [Related]
8. [Metamizole: a 100-year-old misery].
Ned Tijdschr Geneeskd; 1987 May; 131(20):875-6. PubMed ID: 3587424
[No Abstract] [Full Text] [Related]
9. [Metamizole: 100 years of grief].
Offerhaus L
Ned Tijdschr Geneeskd; 1987 Mar; 131(12):479-81. PubMed ID: 3574499
[No Abstract] [Full Text] [Related]
10. [2 cases of allergic agranulocytosis caused by metamizole (sodic noramidopyrine methanesulfonate)].
Puxeddu A; Ferrara G; Scionti L
Clin Ter; 1979 Jul; 90(1):83-8. PubMed ID: 535331
[No Abstract] [Full Text] [Related]
11. [Fatal shock following metamizole].
Berg PA; Becker EW; Erchinger T; Charfi K; Weigand K
Dtsch Med Wochenschr; 1989 Mar; 114(11):443. PubMed ID: 2707128
[No Abstract] [Full Text] [Related]
12. [Agranulocytosis caused by dipyrone. Apropos of a case].
Pueyo Fresneda JA; de la Torre Calatayud A
Rev Esp Anestesiol Reanim; 1986; 33(1):51. PubMed ID: 3704244
[No Abstract] [Full Text] [Related]
13. Marrow toxicity of dipyrone.
Mehta BC
J Assoc Physicians India; 1984 Jul; 32(7):614. PubMed ID: 6501207
[No Abstract] [Full Text] [Related]
14. Dipyrone: a hazardous analgesic?
King B
Ethiop Med J; 1980 Apr; 18(2):77-8. PubMed ID: 7418705
[No Abstract] [Full Text] [Related]
15. Do we continue to prescribe dipyrone (analgin)?
Bharani AK; Mehta RS; Sanghvi VC
J Assoc Physicians India; 1984 Apr; 32(4):382-3. PubMed ID: 6746560
[No Abstract] [Full Text] [Related]
16. Intravenous indomethacin in biliary pain. A clinical investigation with metamizole as the control.
Niinikoski J; Nelimarkka O; Pekkola P
Ann Chir Gynaecol; 1984; 73(2):69-72. PubMed ID: 6465821
[TBL] [Abstract][Full Text] [Related]
17. Agranulocytosis and dipyrone.
Vlahov V; Bacracheva N
Lancet; 1989 Nov; 2(8673):1215. PubMed ID: 2572920
[No Abstract] [Full Text] [Related]
18. [Agranulocytosis caused by dipyrone. Case reports].
Castiglioni F; Broggini M; Baratelli E; Battaglia A; Besozzi M; Gorini L
Clin Ter; 1989 Aug 15-31; 130(3-4):179-83. PubMed ID: 2529092
[TBL] [Abstract][Full Text] [Related]
19. Presumed analgesic-induced agranulocytosis.
Obel AO
East Afr Med J; 1983 Apr; 60(4):273-7. PubMed ID: 6628302
[No Abstract] [Full Text] [Related]
20. Analgesic use, agranulocytosis, and aplastic anemia.
JAMA; 1987 May; 257(19):2590-2. PubMed ID: 3573251
[No Abstract] [Full Text] [Related]
[Next] [New Search]
